Neomycin C

• Description :

  Neomycin C, a tetracyclic antibacterial agent, is a major active isomeric components of the Neomycin complex. Neomycin, is a 2-DOS-containing aminoglycoside, consisting of Neomycin A, Neomycin B, and Neomycin C[1][2].

• UNSPSC :

  12352005

• Target :

  Bacterial

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/neomycin-c.html

• Solubility :

  10 mM in DMSO

• Smiles :

  N[C@@H]1[C@@H](O[C@@H]2[C@H](N)[C@@H](O)[C@H](O)[C@@H](CN)O2)[C@H](O[C@H]3[C@H](O)[C@H](O[C@@H]4[C@H](N)[C@@H](O)[C@H](O)[C@@H](CN)O4)[C@@H](CO)O3)[C@@H](O)[C@H](N)C1

• Molecular Formula :

  C23H46N6O13

• Molecular Weight :

  614.64

• References & Citations :

  [1]Huang F, et al. Elaboration of neosamine rings in the biosynthesis of neomycin and butirosin. Chembiochem. 2007 Feb 12;8 (3) :283-8. |[2]Neomycin C. PubChem.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  Aminoglycoside

• CAS Number :

  [66-86-4]